Inventor · disambiguated record
Kai Lovis
Also filed as: LOVIS KAI
13 granted patents·9 pending applications·22 citations·filing 2000–2025
87Inventor score
Top patents by PatentIndex Score
22 records- 0192US12054481B2Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by racemate separation by means of diastereomeric tartaric acid estersBAYER AG·Filed 2019·Granted Aug 6, 2024·3 cites·34 claims
- 0289US12448381B1Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by racemate separation by means of diastereomeric tartaric acid estersBAYER AG·Filed 2025·Granted Oct 21, 2025·0 cites·20 claims
- 0383US10905667B2Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2018·Granted Feb 2, 2021·2 cites·25 claims
- 0482US10035803B2Synthesis of copanlisib and its dihydrochloride saltBayer Pharma AG·Filed 2015·Granted Jul 31, 2018·7 cites·25 claims
- 0581US2024376103A1Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by racemate separation by means of diastereomeric tartaric acid estersBAYER AG·Filed 2024·Application pending·0 cites
- 0677US12365679B2Process for producing acyloxymethyl esters of (4S)-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylic acidBAYER AG·Filed 2020·Granted Jul 22, 2025·1 cites·15 claims
- 0771US2022234996A1Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical IngredientBayer Pharma AG·Filed 2022·Application pending·0 cites
- 0868US10494372B2Synthesis of copanlisib and its dihydrochloride saltBayer Pharma AG·Filed 2015·Granted Dec 3, 2019·2 cites·19 claims
- 0968US2022257547A1Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2022·Application pending·0 cites
- 1066US11344519B2Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2020·Granted May 31, 2022·0 cites·2 claims
- 1163US11332435B2Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredientBayer Pharma AG·Filed 2018·Granted May 17, 2022·0 cites·1 claims
- 1263US6652782B1Multi-stage method for producing gas-filled microcapsulesSCHERING AG·Filed 2000·Granted Nov 25, 2003·3 cites·38 claims
- 1362US2025326751A1Process for producing acyloxymethyl esters of (4s)-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylic acidBAYER AG·Filed 2025·Application pending·0 cites
- 1459US12358877B2Synthesis of 4-amino-5-methyl-1H-pyridin-2(1H)-on (intermediate compound for the synthesis of the MR antagonist finerenone) from 2-chloro-5-methyl-4-nitro-pyridine-1-oxide using the intermediate compound 2-chloro-5-methyl-4-pyridinamineBAYER AG·Filed 2020·Granted Jul 15, 2025·0 cites·12 claims
- 1556US7067683B2Industrially applicable process for the sulfamoylation of alcohols and phenolsSCHERING AG·Filed 2002·Granted Jun 27, 2006·4 cites·20 claims
- 1655US12398144B2Photochemical process for producing (4R,4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamideBAYER AG·Filed 2020·Granted Aug 26, 2025·0 cites·15 claims
- 1755US2024199599A1Process for the preparation of 2-cyanoethyl (4s)-4-(4-cyano-2-methoxy-phenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate by resolution of racemates by means of diastereomeric tartaric acid estersBAYER AG·Filed 2020·Application pending·0 cites
- 1851US2024300908A1Chiral 3-sulfinyl benzoic acidsBAYER AG·Filed 2022·Application pending·0 cites
- 1948US2022098201A1The monohydrate of rogaratinib hydrochloride and solid states thereofBAYER AG·Filed 2020·Application pending·0 cites
- 2046US2025270204A1Process for the preparation of 2-cyanoethyl (4s)-4-(4-cyano-2-methoxy-phenyl)-5-hydroxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylate by racemate separation by means of diastereomeric tartaric acid estersBAYER AG·Filed 2020·Application pending·0 cites
- 2135US2008269512A1Large Scale Method for the deoxofluorination of ketonesLOVIS KAI·Filed 2007·Application pending·0 cites
- 2232US9359306B2Process for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparationKRÜGER JOACHIM·Filed 2011·Granted Jun 7, 2016·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Kai Lovis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →